April 26, 2024

Heart Attack on a Chip: Replicating Key Aspects of America’s No. 1 Killer

Extreme coronary heart disease can trigger a heart attack, which accounts for much of that discomfort and suffering. Heart attacks happen when fat, cholesterol and other compounds in the coronary arteries badly lower the circulation of oxygen-rich blood to part of the heart. Even if a client makes it through a heart attack, over time they can become significantly fatigued, enervated and sick; some even pass away due to heart failure. A micro layer of protein is then patterned on the top of the chip, “so that the heart cells line up and form the very same architecture that we have in our hearts,” McCain said. That implies they can not mimic what really occurs to damaged heart cells in the so-called border zone after a heart attack, Rexius-Hall stated.

” This allows us to more plainly understand how the heart is changing after a cardiac arrest. From there, we and others can develop and test drugs that will be most reliable for restricting the additional degradation of heart tissue that can occur after a cardiac arrest,” included McCain.
McCain, a “cardiac tissue engineer,” whose work formerly consisted of co-developing a heart on a chip, and Rexius-Hall detail their findings in a recently released post in the journal Science Advances entitled “A Myocardial Infarct Border-Zone-On-A-Chip Demonstrates Distinct Regulation of Cardiac Tissue Function by an Oxygen Gradient.”
Americas No. 1 killer
Severe coronary heart illness can trigger a heart attack, which accounts for much of that pain and suffering. Heart attacks happen when fat, cholesterol and other substances in the coronary arteries significantly decrease the flow of oxygen-rich blood to part of the heart.
Even if a client endures a cardiac arrest, with time they can become progressively tired, enervated and ill; some even pass away due to heart failure. Thats due to the fact that heart cells do not regrow like other muscle cells. Instead, immune cells appear at the site of injury, some of which can be harmful. Additionally, scarring develops that compromises the heart and the quantity of blood it can pump.
Microscale model developed by USC researchers Megan Mccain and Megan Rexius that can replicate crucial elements of myocardial infarction and may one day act as a testbed for brand-new tailored heart drugs. Credit: Megan Rexius
Nevertheless, scientists dont completely understand this procedure, especially how heart cells in the injured and healthy parts of the heart communicate with each other and how and why they change after a heart attack.
McCain and Rexius-Hall believe their cardiovascular disease on a chip can shed some light on those secrets.
” Fundamentally, we desire to have a model that can lead to a better understanding of cardiovascular disease injury,” Rexius-Hall said.
Cardiac arrest On a Chip.
The heart attack on a chip is literally constructed from the ground up. At the base is a 22-millimeter-by-22-millimeter square microfluidic device slightly larger than a quarter– made from a rubber-like polymer called PDMS– with two channels on opposing sides through which gases flow. Above that sits a very thin layer of the same rubber product, which is permeable to oxygen. A micro layer of protein is then patterned on the top of the chip, “so that the heart cells align and form the same architecture that we have in our hearts,” McCain stated. Rodent heart cells are grown atop the protein.
To imitate a cardiovascular disease, gas with oxygen and gas without oxygen is released through each channel of the microfluidic gadget, “exposing our heart on a chip to an oxygen gradient, comparable to what really happens in a cardiovascular disease,” McCain said.
Since the microfluidic device is small, clear, and easy to see on a microscopic lense, McCain included, it likewise allows scientists to observe in real-time functional modifications that in some cases happen in the heart after an attack, consisting of an arrhythmia, or an irregular heart beat, and contractile dysfunction, or decreases in the contraction strength of the heart. In the future, scientists can make the design more complex by including immune cells or fibroblasts, the cells that produce the scar after a cardiovascular disease.
By contrast, researchers can not enjoy modifications to heart tissue in real-time with animal models. Furthermore, standard cell culture designs consistently expose heart cells to high, medium or low levels of oxygen, but not a gradient. That means they can not mimic what actually occurs to broken heart cells in the so-called border zone after a cardiac arrest, Rexius-Hall stated.
Added McCain: It is rewarding and very amazing to envision our device having a favorable influence on client lives in the near future, particularly for cardiac arrest, which are extremely prevalent.”.
Reference: “A myocardial infarct border-zone-on-a-chip demonstrates distinct guideline of cardiac tissue function by an oxygen gradient” 7 December 2022, Science Advances.DOI: 10.1126/ sciadv.abn7097.
Other co-authors on this paper include Natalie Khalil, a USC Viterbi Ph.D. student in biomedical engineering; Sean Escopete and Sarah Parker of the Smidt Heart Institute at Cedars-Sinai Medical Center; and Xin Li, Jiayi Hu, Hongyan Yuan of the Department of Mechanics and Aerospace Engineering at Southern University of Science and Technology in China.
The National Heart, Lung, and Blood Institute and the American Heart Association (AHA) supported this research study.

Scientists have developed a “cardiac arrest on a chip” that reproduces some key features of a cardiovascular disease in a easy-to-use and fairly simple system. It could one day function as a testbed to develop new heart drugs and even individualized medicine.
USC researchers Megan McCain and postdoc Megan Rexius-Hall have crafted a microscale design that can duplicate crucial elements of myocardial infarction and might one day function as a testbed for new customized heart drugs.
A “cardiac arrest on a chip”– a device that could one day serve as a testbed to establish new heart drugs and even tailored medicines– has been developed by researchers at the University of Southern California (USC) Alfred E. Mann Department of Biomedical Engineering.
” Our gadget reproduces some key features of a cardiac arrest in a reasonably simple and easy-to-use system,” said Megan McCain, an associate teacher of biomedical engineering and stem cell biology and regenerative medicine, who developed the gadget with postdoctoral scientist Megan Rexius-Hall.